Shuangpeng Pu

Dr. Shuangpeng Pu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GLGuodong Li
Guodong Li
SPShuangpeng Pu
Shuangpeng Pu
LYLisiyao You
Lisiyao You
YGYuan Gao
Yuan Gao
YZYuexia Zhong
Yuexia Zhong
XLXiyan Lu
Xiyan Lu
Outer membrane vesicles (OMVs) are double-layered structures of nanoscale lipids released by gram-negative bacteria. They have the same membrane composition and characteristics as primitive cells, which enables them to penetrate cells and tissues efficiently. These OMVs exhibit excellent membrane stability, immunogenicity, safety, and permeability (which makes it easier for them to penetrate into tumour tissue), making them suitable for developing cancer vaccines and drug delivery systems. Recent studies have focused on engineering OMVs to enhance tumour-targeting capabilities, reduce toxicity, and extend circulation time in vivo. This article reviews the latest progress in OMV engineering for tumour treatment and discusses the challenges associated with the use of OMV-based antitumour therapy in clinical practice.